Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Jim Birchenough
Recent news which mentions Jim Birchenough
Gilead Analysts See Questionable Commercial Opportunity For Coronavirus Candidate Remdesivir
May 01, 2020
Tickers
GILD
UBS
Tags
Reiteration
Morgan Stanley
Coronavirus
From
Benzinga
Gilead Analysts Tackle Early Results From Remdesivir Study In COVID-19, Morgan Stanley Says Stock Move Looks Overdone
April 17, 2020
Tickers
GILD
Tags
Wells Fargo
Tigress Financial
Morgan Stanley
From
Benzinga
Gilead Analysts Break Down Remdesivir Data Readout From Compassionate Use
April 13, 2020
Tickers
GILD
Tags
Analyst Color
Covid/19
Market News
From
Benzinga
Wells Fargo Upgrades Fate Therapeutics On Induced Pluripotent Stem Cell Outlook
December 09, 2019
Tickers
FATE
Tags
Wells Fargo
Analyst Ratings
Jim Birchenough
From
Benzinga
Analysts Focus On Gilead's Late-Stage Data Readouts Following Mixed Q4
February 05, 2019
Tickers
GILD
Tags
Analyst Color
Market News
Top Stories
From
Benzinga
Wells Fargo Bullish On Applied Genetic Technologies Ahead Of Program Update
September 24, 2018
Tickers
AGTC
BIIB
NITE
Tags
BIIB
Biotech
AGTC
From
Benzinga
After Biogen's Alzheimer's Update, Wall Street Reacts
July 06, 2018
Tickers
BIIB
Tags
Laura Chico
General
BAN2401
From
Benzinga
Uniqure Notches Bullish Initiation On Gene Therapy Prospects
May 20, 2018
Tickers
BMY
IONS
QURE
RHHBY
Tags
General
IONS
Analyst Ratings
From
Benzinga
Jounce Therapeutics Stock Slides On Disappointing Data, Wells Fargo Downgrades
May 17, 2018
Tickers
JNCE
NEWS
Tags
Price Target
Events
Market News
From
Benzinga
Bellicum Rallies After FDA Lifts Clinical Hold
April 12, 2018
Tickers
BLCM
NEWS
Tags
Benzinga
Jim Birchenough
Wells Fargo
From
Benzinga
Akcea Therapeutics Downgraded By Wells Fargo After Huge Run
March 19, 2018
Tickers
AKCA
IONS
NEWS
Tags
Analyst Ratings
IONS
General
From
Benzinga
Wall Street Reacts To Celgene's Reported Interest In Juno
January 17, 2018
Tickers
BLUE
CART
CELG
JUNO
Tags
Biotech
Matthew Harrison
CELG
From
Benzinga
Arena Pharma Upgraded Ahead Of Clinical Data Release
January 03, 2018
Tickers
ARNA
Tags
ARNA
Biotech
Upgrades
From
Benzinga
Infinity Pharmaceuticals Notches Upgrade Ahead Of Cancer Conference Presentation
October 12, 2017
Tickers
INFI
Tags
Jim Birchenough
General
Analyst Ratings
From
Benzinga
FDA Warning Letter Buckles Intercept Pharma Shares; Wells Fargo Downgrades
September 22, 2017
Tickers
ICPT
NEWS
Tags
Analyst Color
FDA
Jim Birchenough
From
Benzinga
Analysts Weigh In On Gilead-Kite Pharma Deal
August 29, 2017
Tickers
GILD
KITE
NEWS
Tags
Phil Nadeau
Price Target
Analyst Color
From
Benzinga
Clinical Hold For Regulus' RG101 Sparks A Downgrade At Wells Fargo
January 30, 2017
Tickers
NEWS
RGLS
Tags
Price Target
Analyst Color
RGLS
From
Benzinga
Legal Experts Weigh In On The Amgen/Regeneron Patent Case
January 09, 2017
Tickers
AMGN
NEWS
REGN
SNY
Tags
Health Care
News
Wells Fargo
From
Benzinga
Global Blood Therapeutics Shares Spiking On Analyst's Positive Outlook
September 30, 2016
Tickers
GBT
Tags
Price Target
Movers
Analyst Color
From
Benzinga
Ziopharm Oncology Downgraded By BMO As 'Questions Persist'
June 22, 2015
Tickers
ZIOP
Tags
Downgrades
Analyst Ratings
Jim Birchenough
From
Benzinga
BMO: Celgene Still A Buy On This 'Important Future Driver'
May 28, 2015
Tickers
CELG
Tags
Analyst Color
CELG
BMO Capital
From
Benzinga
BMO Capital: Five Prime Therapeutics Still A Buy, Worth $31/Share Now
May 28, 2015
Tickers
BLUE
FPRX
Tags
BMO Capital
Analyst Color
BLUE
From
Benzinga
Regeneron Shares Fall Following BMO's Note Of Roche Preference
June 20, 2014
Tickers
BMO
REGN
Tags
BMO
Analyst Color
Short Ideas
From
Benzinga
Ariad Shares Continue to Surge Amidst Buyout Rumors
January 24, 2014
Tickers
ARIA
GSK
LLY
SHPG
Tags
News
Jim Birchenough
US37733W1053
From
Benzinga
UPDATE: BMO Capital Markets Upgrades Tesaro
January 21, 2014
Tickers
TSRO
Tags
Analyst Ratings
Jim Birchenough
Benzinga
From
Benzinga
Tesaro Shares Tumble After Disappointing Data Results
December 23, 2013
Tickers
TSRO
Tags
Benzinga
BMO Capital Markets
Analyst Color
From
Benzinga
UPDATE: BMO Capital Markets Reiterates on Receptos Following Solid 3Q13 Operating Results
October 31, 2013
Tickers
RCPT
Tags
RCPT
BMO Capital Markets
Analyst Color
From
Benzinga
UPDATE: BMO Capital Markets Downgrades Ariad Pharmaceuticals on AP26113 Disappointment, Tempered ICLUSIG Expectations
September 30, 2013
Tickers
ARIA
Tags
BMO Capital Markets
Analyst Color
US04033A1007
From
Benzinga
UPDATE: BMO Capital Markets Raises PT on Regulus Therapeutics Following 2Q13 Operating Results
August 14, 2013
Tickers
RGLS
Tags
Analyst Ratings
Jim Birchenough
Benzinga
From
Benzinga
UPDATE: BMO Capital Markets Raises PT on Intercept Pharmaceuticals Following 2Q13 Operating Results
August 14, 2013
Tickers
ICPT
Tags
BMO Capital Markets
Analyst Color
Price Target
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.